NK cells express a superfamily of surface proteins that share a common
structure: dimeric type II integral membrane proteins whose extracell
ular domains have structural features of C-type (calcium-dependent) le
ctins. These receptors are encoded in a single genetic region called t
he NK complex (NKC). The NKC encompasses several families of genes, in
cluding Ly-49 (in mice and rats), NKR-P1 (in mice, rats, and humans),
NKG2 (in humans and rats), and CD94 (in humans). Different NKC recepto
rs have been shown to activate or to inhibit NR function, and differen
t receptors within the same family can have opposing functions. In thi
s review, we discuss the molecular pathways by which NK cells are acti
vated, and the mechanisms by which inhibitory receptors interrupt acti
vation. By studying the inhibitory receptor Ly-49A, we have demonstrat
ed that inhibition utilizes the cytoplasmic phosphatase, SHP-1, which
binds to a motif in the receptor cytoplasmic domain, termed an immunor
eceptor tyrosine-based inhibitory motif (ITIM). In this regard, the le
ctin-like receptors are functionally similar to the immunoglobulin-lik
e killer inhibitory receptors (KIRs) on human NK cells. The presence o
f an ITIM generally correlates with inhibitory activity among NKC lect
in-like receptors, as demonstrated by the human NKG2 receptor family L
anier and his colleagues have recently shown that NKG2 receptors can f
orm heterodimers with the invariant lectin-like receptor CD94. Selecti
ve association of CD94 with different NKG2 receptors may explain funct
ional differences for CD94 in different NK clones.